SITAPRIDE D 100/10

About

SITAPRIDE D 100/10 combines Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, offering a synergistic approach to managing type 2 diabetes mellitus. Sitagliptin works by enhancing the body's natural incretin hormones, which leads to increased insulin synthesis and release from pancreatic beta cells and decreased glucagon secretion from alpha cells, particularly in a glucose-dependent manner. Dapagliflozin acts independently of insulin by inhibiting SGLT2 in the renal tubules, thereby reducing glucose reabsorption and increasing glucose excretion in the urine. This dual mechanism effectively lowers elevated blood glucose levels, improves glycemic control, and reduces HbA1c. The combination is particularly beneficial for patients who have not achieved adequate glycemic targets with monotherapy or who can benefit from the additional cardiovascular and renal protective effects associated with SGLT2 inhibitors. It also contributes to modest weight loss and blood pressure reduction.

Uses

• Management of type 2 diabetes mellitus.
• To improve glycemic control in adults.
• When diet and exercise alone are insufficient.
• As an add-on to other antidiabetic agents.

Directions For Use

Take orally once daily, with or without food, as directed by your physician. Swallow the tablet whole with water.

Benefits

• Comprehensive blood sugar control.
• Reduces HbA1c levels effectively.
• May aid in weight management.
• Provides cardiovascular benefits.
• Offers renal protective effects.
• Convenient once-daily dosing.

Side Effects

• Urinary tract infections
• Genital yeast infections
• Nausea
• Diarrhea
• Headache
• Dizziness
• Hypoglycemia (especially with other agents)
• Increased urination
• Back pain
• Joint pain
• Nasopharyngitis
• Ketoacidosis (rare)

Safety Measures

• Alcohol - Limit alcohol intake as it can increase the risk of hypoglycemia.
• Pregnancy - Generally not recommended during pregnancy. Consult a doctor as benefits must outweigh risks.
• Breastfeeding - Not recommended during breastfeeding due to potential excretion into breast milk.
• Liver - Use with caution in patients with moderate to severe hepatic impairment. Dose adjustment may be necessary.
• Kidney - Contraindicated in severe renal impairment or end-stage renal disease. Dose adjustment required for moderate impairment.
• Lung - Generally safe for use in patients with lung conditions. No specific contraindications related to lung function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.